The effects of clozapine on cognitive functioning in schizophrenia

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 12, 1999, Pages 24-29

  McGurk, Susan R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE; ZOTEPINE;

ATTENTION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MEMORY; PERFORMANCE; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; QUALITY OF LIFE; REVIEW; SCHIZOPHRENIA; UNEMPLOYMENT; VERBAL BEHAVIOR; WORKING MEMORY;

ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS; CLOZAPINE; COGNITION; COGNITION DISORDERS; HUMANS; MEMORY; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; VERBAL LEARNING; VISUAL PERCEPTION;

EID: 0033018724     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Saykin AJ, Shtasel DL, Gur RE, et al. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry 1994;51:124-131
2. Fish B. Neurobiologic antecedents of schizophrenia in children: evidence for an inherited, congenital neurointegrative defect. Arch Gen Psychiatry 1977;34:1297-1313
3. Hoff AL, Riordan H, O'Donnell DW, et al. Neuropsychological functioning of first-episode schizophreniform patients. Am J Psychiatry 1992; 149: 898-903
4. Waddington JL, Ycussef HA. Cognitive dysfunction in chronic schizophrenia followed irrespectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia. Psychol Med 1996;26:681-688
5. Davidson M, Harvey P, Welsch KA, et al. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease. Am J Psychiatry 1996;153:1274-1279
6. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996;153:321-330
7. Cassens G, Inglis AK, Appelbaum PS, et al. Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients. Schizophr Bull 1990;16:477-499
8. Gold JM, Harvey PD. Cognitive deficits in schizophrenia. Psychiatr Clin North Am 1993;16:295-312
9. Goldberg TE, Torrey EF, Gold JM, et al. Learning and memory in monozygotic twins discordant for schizophrenia. Psychol Med 1993;23:71-85
10. Mulkern VM, Manderscheid RW. Characteristics of community support program clients in 1980 and 1984. Hosp Community Psychiatry 1989;40: 165-172
11. Sevy S, Davidson M. The cost of cognitive impairment in schizophrenia. Schizophr Res 1995;17:1-3
12. Meltzer HY, McGurk SR. The effect of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull. In press
13. Goldman RS, Axelrod BN, Tandon R, et al. Neuropsychological prediction of treatment efficacy and one-year outcome in schizophrenia. Psychopathology 1993;26:122-126
14. Lysaker P, Bell M, Beam-Goulet J. Wisconsin Card Sorting Test and work performance in schizophrenia. Psychiatry Res 1995;56:45-51
15. Jaeger J, Douglas E. Neuropsychiatrie rehabilitation for persistent mental illness. Psychiatr Q 1992;63:71-94
16. Goldberg TE, Greenberg RD, Griffin SJ, et al. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 1993;162:43-48
17. Hagger C, Buckley P, Kenny JT, et al. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Biol Psychiatry 1993;34:702-712
18. Buchanan RW, Holstein C, Breier A. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biol Psychiatry 1994;36:717-725
19. Lee MA, Thompson PA, Meltzer HY. Effects of clozapine on cognitive function in schizophrenia. J Clin Psychiatry 1994;55 (7, suppl B):82-87
20. Zahn TP, Pickar D, Haier RJ. Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia. Schizophr Res 1994;13:133-144
21. Daniel DG, Goldberg TE, Weinberger DR, et al. Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study. Am J Psychiatry 1996;153:417-419
22. Grace J, Bellus SB, Raulin ML, et al. Long-term impact of clozapine and psychosocial treatment on psychiatric symptoms and cognitive functioning. Psychiatr Serv 1996;47:41-45
23. Hoff AL, Faustman WO, Wieneke M, et al. The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic patients. Neuropsychopharmacology 1996;15:361-369
24. Fujii DE, Ahmed I, Jokumsen M, et al. The effects of clozapine on cognitive functioning in treatment-resistant schizophrenic patients. J Neuropsychiatry Clin Neurosci 1997;9:240-245
25. Galletly CA, Clark CR, McFarlane AC, et al. Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine. Psychiatry Res 1997;72:161-166
26. Meyer-Lindenberg A, Gruppe H, Bauer U, et al. Improvement of cognitive functioning in schizophrenic patients receiving clozapine or zotepine: results from a double-blind study. Pharmacopsychiatry 1997;30:35-42
27. Lindenmayer J-P, Iskander A, Park M, et al. Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory patients: a prospective study. J Clin Psychiatry 1998;59:521-527
28. Spohn HE, Strauss ME. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J Abnorm Psychol 1989;98: 367-380
29. Lindström LH. Long-term clinical and social outcome studies in schizophrenia in relation to the cognitive and emotional side effects of antipsychotic drugs. Acta Psychiatr Scand 1994;89(suppl 380):74-76
30. Meltzer HY. Cognitive and other nonconventional benefits of clozapine treatment. J Clin Psychiatry Monograph 1996:14(2):22-23
31. Meltzer HY, Burnett S, Bastani B, et al. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry 1990;41:892-897